Candida Vaginitis. Candidiasis of Vulva and Vagina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: signs and symptoms of Candida vaginitis, positive direct smear of vaginal discharge Exclusion criteria: pregnant women, low compliance, any drug hypersensitivity, recurrent Candida vaginitis (4 or more Candida vaginitis in a year), consumption of immunosuppressive drug or widespread antibiotics, history of epilepsy, diabetes, heart disease, high blood pressure, thyroid diseases, or advanced arthritis, using other vaginal creams or suppositories during the study period, consumption of systemic antifungal drugs during 4 weeks prior to the study, presence of non-candidal vaginitis, consumption of oral contraceptives.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Discharge. Timepoint: Baseline and3 to 4 Days after treatment. Method of measurement: Clinical Examination, observation, and medical history.;Pruritus. Timepoint: Baseline and 3 to 4 Days after treatment. Method of measurement: History.;Edema. Timepoint: Baseline and 3 to 4 Days after treatment. Method of measurement: Clinical Examination, observation, and medical history.;Erythema symptoma. Timepoint: Baseline and 3 to 4 Days after treatment. Method of measurement: Clinical Examination, Observation, and History.;Dysuria Symptom. Timepoint: Baseline and 3-4 Days after treatment. Method of measurement: History.;Dysparonia Symptom. Timepoint: Baseline and 3 to 4 Days after the treatment. Method of measurement: History.;Culture results. Timepoint: 3 to 4 Days after Treatment. Method of measurement: Wet Smear and Vaginal Culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences